← Leaderboards
Prema Robinson
Baylor College Of Medicine
$3,410,225
Attributed
$3,410,225
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,410,225 · 9
By mechanism
N01$1,293,012 · 1
R01$1,189,586 · 1
R21$412,980 · 1
P51$358,147 · 5
R03$156,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Robert Shulman$22,095,118
- David John Tweardy$14,168,425
- Xiangwei Wu$7,480,443
- Eva H Clark$955,291
- Linda Rabeneck$128,846
Others in their field
Top investigators on “Substance P”
- Jeffery Dill · Battelle Centers/Pub Hlth Res & Evaluatn$19,083,129
- Eric M Reiman · Banner Health$18,207,224
- Pierre N. Tariot · University Of Rochester$16,630,118
- James S Frederick · Steelworker Charitable/Educational Org$15,243,480
- George Kenneth Lewis · Zetroz, Inc.$13,383,396
- Michael J. Detke · Embera Neurotherapeutics, Inc.$12,591,952
Research focus
Substance PDiarrheaCryptosporidiosisPathogenesisResearch PersonnelCryptosporidiumProtein Quantitation /DetectionProteinsLifeIntestinesSubstance P ReceptorNeuropeptide ReceptorMessenger RnaEnzyme Linked Immunosorbent AssayEnzyme-Linked Immunosorbent AssayEpilepsyCryptosporidium ParvumInterleukin 6Laboratory MouseImmunohistochemistryComputer Retrieval Of Information On Scientific Projects DatabaseInfectionChloride IonHuman Tissue
Grant awards (16)
FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION$1,293,012
N01 · FY2023 · CA · contact PI
Role of STAT3 in the pathogenesis of Inflammatory Bowel Disease$78,250
R03 · FY2014 · AI · contact PI
Role of STAT3 in the pathogenesis of Inflammatory Bowel Disease$78,250
R03 · FY2013 · AI · contact PI
SUBSTANCE P AND THE PATHOGENESIS OF CRYPTOSPORIDIOSIS IN AIDS$58,149
P51 · FY2009 · RR · contact PI
SUBSTANCE P AND THE PATHOGENESIS OF CRYPTOSPORIDIOSIS IN AIDS$63,253
P51 · FY2008 · RR · contact PI
Neuropeptides in the pathogenesis of neurocysticercosis$225,912
R01 · FY2007 · NS · contact PI
SUBSTANCE P AND THE PATHOGENESIS OF CRYPTOSPORIDIOSIS IN AIDS$71,638
P51 · FY2007 · RR · contact PI
Neuropeptides in the pathogenesis of neurocysticercosis$232,999
R01 · FY2006 · NS · contact PI
SUBSTANCE P AND THE PATHOGENESIS OF CRYPTOSPORIDIOSIS IN AIDS$65,435
P51 · FY2006 · RR · contact PI
Neuropeptides in the pathogenesis of neurocysticercosis$238,944
R01 · FY2005 · NS
SUBSTANCE P AND THE PATHOGENESIS OF CRYPTOSPORIDIOSIS IN AIDS$52,511
P51 · FY2005 · RR
Neuropeptides in the pathogenesis of neurocysticercosis$242,395
R01 · FY2004 · NS
Substance P in pathogenesis of cryptosporidiosis in AIDS$203,300
R21 · FY2004 · AI
SUBSTANCE P: PATHOGENESIS OF CRYPTOSPORIDIOSIS IN AIDS$47,161
P51 · FY2004 · RR
Neuropeptides in the pathogenesis of neurocysticercosis$249,336
R01 · FY2003 · NS
Substance P in pathogenesis of cryptosporidiosis in AIDS$209,680
R21 · FY2003 · AI